Please login to the form below

Not currently logged in
Email:
Password:

Kantar Media and Pointlogic unveil comms planning platform

Will determine most appropriate channel for reaching target audiences

New York-based agency Kantar Media is collaborating with software provider Pointlogic to develop a communications planning platform within the US consumer health sector.

Launching next month, Commspoint MARS is a communications channel planning tool for the pharmaceutical industry, developed by Pointlogic and run with Kantar Media data.

The technology will allow clients to determine the most appropriate channels for reaching target audiences as they search for remedies for various ailments.

It will then help clients develop communications plans using appropriate messaging and strategy drivers related to a specific ailment.

The data is gathered from Kantar Media's MARS Consumer Healthcare study, which provides consumption information, covering ailment conditions (including treatment options), prescription and over-the-counter drug brand usage, attitudinal and behavioural information concerning pharmaceutical and healthcare and consumer segmentation analysis.

19th June 2013

From: Marketing

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground”...

Latest intelligence

The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...